Skip to content

Clinical trials

Completed Schizophrenia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: United States Clear all

1,075 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200120
200227
200341
200456
200550
200657
200761
200856
200953
201061
201155
201253
201353
201456
201543
201639
201735
201837
201934
202033
202141
202228
202323
202410
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,075

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.60
University of Maryland, Baltimore49
VA Office of Research and Development40
Yale University40
Dartmouth-Hitchcock Medical Center28
National Institute of Mental Health (NIMH)26
US Department of Veterans Affairs26
Massachusetts General Hospital24
Sumitomo Pharma America, Inc.22
University of California, San Diego20

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia1,075
Psychotic Disorders426
Bipolar Disorder136
Mental Disorders77
Major Depressive Disorder44
Obesity25
Substance-Related Disorders22
Tobacco Use Disorder22
Hallucinations19
Diabetes Mellitus18

Trials

Showing 1 to 25 of 1,075. Each trial links to its page on Pharma Observatory.

975 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.